Mankind Pharma Limited — Credit Ratings, 12-05-2026: Credit Rating

ICRA Limited has reaffirmed Mankind Pharma's credit ratings. Long-term fund-based limits and Non-convertible Debentures are rated [ICRA]AA+ (Stable). Short-term fund-based limits and Commercial Paper are rated [ICRA]A1+. ICRA also assigned a new rating for Commercial Paper. The 'Stable' outlook confirms the company's robust creditworthiness and strong financial health.